Onconetix annual depreciation and amortization
2021
2022
2023
2024
2025
Onconetix Depreciation & Amortization Growth & History (ONCO)
Onconetix's depreciation and amortization was $15,170 for fiscal 2025.
View full Onconetix company overviewOnconetix annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $15,170 | −$716,175 | −97.93% |
| 2024 | 2024-12-31 | $731,345 | $687,408 | +1564.53% |
| 2023 | 2023-12-31 | $43,937 | $37,185 | +550.73% |
| 2022 | 2022-12-31 | $6,752 | $1,862 | +38.08% |
| 2021 | 2021-12-31 | $4,890 | — | — |
Onconetix quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2,632 | −$1,067 | −28.85% |
| Q1 2026 | 2026-03-31 | $5,398 | $650 | +13.69% |
| Q4 2025 | 2025-12-31 | $3,336 | — | — |
| Q3 2025 | 2025-09-30 | $3,387 | −$200,658 | −98.34% |
| Q2 2025 | 2025-06-30 | $3,699 | −$197,602 | −98.16% |
| Q1 2025 | 2025-03-31 | $4,748 | −$201,952 | −97.70% |
| Q3 2024 | 2024-09-30 | $204,045 | $202,428 | +12518.74% |
| Q2 2024 | 2024-06-30 | $201,301 | $199,730 | +12713.56% |
| Q1 2024 | 2024-03-31 | $206,700 | $205,002 | +12073.14% |
| Q3 2023 | 2023-09-30 | $1,617 | −$228 | −12.36% |
| Q2 2023 | 2023-06-30 | $1,571 | −$190 | −10.79% |
| Q1 2023 | 2023-03-31 | $1,698 | $398 | +30.62% |
| Q3 2022 | 2022-09-30 | $1,845 | $586 | +46.54% |
| Q2 2022 | 2022-06-30 | $1,761 | $515 | +41.33% |
| Q1 2022 | 2022-03-31 | $1,300 | $68 | +5.52% |
| Q3 2021 | 2021-09-30 | $1,259 | — | — |
| Q2 2021 | 2021-06-30 | $1,246 | — | — |
| Q1 2021 | 2021-03-31 | $1,232 | — | — |
Onconetix depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Onconetix's depreciation and amortization increased from $4,890 to $15,170, a change of $10,280. The latest reported quarter, Q2 2026, shows $2,632.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Onconetix source filings ↗